Agile Therapeutics Inc. | Mutual Funds
Mutual Funds that own Agile Therapeutics Inc.
Old Mutual Invt. Funds Series II - Asian Pacific Fund
1,842,000
5.36%
518,000
0.12%
10/31/2017
Franklin Biotechnology Discovery Fund
1,179,371
3.43%
180,271
0.02%
03/31/2018
Vanguard Total Stock Market Index Fund
754,951
2.2%
0
0%
07/31/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
385,205
1.12%
-1,790,624
0.01%
06/30/2018
Needham Small Cap Growth Fund
260,000
0.76%
28,706
0.23%
03/31/2018
Vanguard Extended Market Index Fund
241,958
0.7%
0
0%
07/31/2018
AXA Rosenberg Global Invt. Company ICVC - Global Fund
126,000
0.37%
126,000
0.01%
01/31/2018
APO Medical Opportunities Institutionell
123,000
0.36%
30,000
0.02%
06/29/2018
Bridgeway Ultra Small Company Market Fund
123,000
0.36%
0
0.01%
12/31/2017
Needham Growth Fund
116,294
0.34%
-5,000
0.03%
03/31/2018
| Address |
101 Poor Farm Road
Princeton New Jersey 08540
United States
|
|
Employees
|
- |
| Website |
http://www.agiletherapeutics.com |
| Updated |
07/08/2019 |
| Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch for use in contraception. It offers its product candidate Twirla, which is an investigational non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ. |
